HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

monoclonal antibody CNTO 328

a chimeric anti-interleukin-6 antibody for treatment of multiple myeloma and renal cell carcinoma; in phase I and phase II clinical trials
Also Known As:
CNTO 328 monoclonal antibody; cClB8 monoclonal antibody; monoclonal antibody CNTO-328; monoclonal antibody CNTO328; siltuximab
Networked: 42 relevant articles (4 outcomes, 21 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Qi, Ming: 10 articles (10/2015 - 08/2010)
2. van de Velde, Helgi: 10 articles (10/2015 - 05/2013)
3. Reddy, Manjula: 10 articles (10/2015 - 09/2011)
4. Qin, Xiang: 7 articles (10/2015 - 08/2010)
5. van Rhee, Frits: 7 articles (10/2015 - 08/2010)
6. Puchalski, Thomas A: 7 articles (05/2015 - 06/2013)
7. Kurzrock, Razelle: 6 articles (01/2016 - 08/2010)
8. Vermeulen, Jessica: 6 articles (10/2015 - 09/2011)
9. Casper, Corey: 6 articles (10/2015 - 08/2010)
10. Bandekar, Rajesh: 6 articles (10/2015 - 01/2014)

Related Diseases

1. Neoplasms (Cancer)
2. Multiple Myeloma
3. Lung Neoplasms (Lung Cancer)
4. Prostatic Neoplasms (Prostate Cancer)
5. Giant Lymph Node Hyperplasia (Castleman's Disease)

Related Drugs and Biologics

1. Interleukin-6 (Interleukin 6)
2. bortezomib (Velcade)
3. tocilizumab
4. Prednisone (Sone)
5. docetaxel (Taxotere)
6. Melphalan (Alkeran)
7. Interleukins
8. STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
9. Biological Markers (Surrogate Marker)
10. Mitoxantrone (Novantrone)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Castration
3. Drug Therapy (Chemotherapy)
4. Investigational Therapies (Experimental Therapy)
5. Transplants (Transplant)